GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » Altman Z-Score

We Can Medicines Co (ROCO:6929) Altman Z-Score : 2.12 (As of Jun. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is We Can Medicines Co Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 2.13 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.

We Can Medicines Co has a Altman Z-Score of 2.12, indicating it is in Grey Zones. This implies that We Can Medicines Co is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for We Can Medicines Co's Altman Z-Score or its related term are showing as below:

ROCO:6929' s Altman Z-Score Range Over the Past 10 Years
Min: 2.13   Med: 2.64   Max: 3.38
Current: 2.13

During the past 4 years, We Can Medicines Co's highest Altman Z-Score was 3.38. The lowest was 2.13. And the median was 2.64.


We Can Medicines Co Altman Z-Score Historical Data

The historical data trend for We Can Medicines Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

We Can Medicines Co Altman Z-Score Chart

We Can Medicines Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Altman Z-Score
- - - 2.55

We Can Medicines Co Quarterly Data
Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 3.38 2.73 2.55 2.23

Competitive Comparison of We Can Medicines Co's Altman Z-Score

For the Packaged Foods subindustry, We Can Medicines Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


We Can Medicines Co's Altman Z-Score Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where We Can Medicines Co's Altman Z-Score falls into.



We Can Medicines Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

We Can Medicines Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1719+1.4*0.0223+3.3*0.0113+0.6*1.4801+1.0*0.9586
=2.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was NT$3,306 Mil.
Total Current Assets was NT$1,624 Mil.
Total Current Liabilities was NT$1,056 Mil.
Retained Earnings was NT$74 Mil.
Pre-Tax Income was 13.977 + 7.712 + -5.677 + -4.575 = NT$11 Mil.
Interest Expense was -7.695 + -6.663 + -5.675 + -5.797 = NT$-26 Mil.
Revenue was 818.097 + 812.202 + 774.279 + 764.839 = NT$3,169 Mil.
Market Cap (Today) was NT$3,165 Mil.
Total Liabilities was NT$2,139 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(1624.385 - 1055.948)/3306.239
=0.1719

X2=Retained Earnings/Total Assets
=73.626/3306.239
=0.0223

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(11.437 - -25.83)/3306.239
=0.0113

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3165.305/2138.52
=1.4801

X5=Revenue/Total Assets
=3169.417/3306.239
=0.9586

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

We Can Medicines Co has a Altman Z-Score of 2.12 indicating it is in Grey Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


We Can Medicines Co  (ROCO:6929) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


We Can Medicines Co Altman Z-Score Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


We Can Medicines Co (ROCO:6929) Business Description

Traded in Other Exchanges
N/A
Address
Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.

We Can Medicines Co (ROCO:6929) Headlines

No Headlines